Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices - Phase II (U01)

The summary for the Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices - Phase II (U01) grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices - Phase II (U01): -The original RFA for the Work, Family, and Health Network (WFHN) provided funding for six teams of interdisciplinary scholars to develop a conceptual and methodological framework, select measurement tools, and design an intervention to serve as the basis for an evaluation of the health benefits of workplace policies and practices aimed at ameliorating work-family conflict. The purpose of this RFA is to maintain the momentum of discovery and further develop research building upon that planning period. In this second phase, the WFHN will implement the intervention and conduct a longitudinal evaluation of its benefits for the health of workers, workers families, and employers. -This Funding Opportunity Announcement (FOA) will utilize the U01 grant mechanism. -The participating organizations intend to commit approximately $5.8 million in total costs [Direct plus Facilities and Administrative (F and A) costs] each year for five years to fund up to six proposals in response to this RFA. The total amount awarded will depend upon the scientific merit and program relevance of the applications received, and the amount of funds available.
Federal Grant Title: Limited Competition for Evaluating the Health Benefits of Workplace Policies and Practices - Phase II (U01)
Federal Agency Name: National Institutes of Health
Grant Categories: Income Security and Social Services Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-HD-07-101
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.26293.865
CFDA Descriptions: Occupational Safety and Health Program 93.865 Child Health and Human Development Extramural Research
Current Application Deadline: No deadline provided
Original Application Deadline: Jan 29, 2008
Posted Date: Nov 27, 2007
Creation Date: Nov 27, 2007
Archive Date: Feb 29, 2008
Total Program Funding: $5,800,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards:
Cost Sharing or Matching: 93.866 -- Aging Research
Applicants Eligible for this Grant
Public and State controlled institutions of higher education For profit organizations other than small businesses Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Small businesses State governments Others (see text field entitled "Additional Information on Eligibility" for clarification) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Additional Information on Eligibility
Foreign institutions are eligible to apply. Eligible agencies of the Federal Government can apply. Faith-based or community-based organizations can apply.
Link to Full Grant Announcement
Information not provided
Grant Announcement Contact
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV
FBOWebmaster@OD.NIH.GOV If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
More Grants from the National Institutes of Health
Accelerating Discovery of Efficacious Pre-erythrocytic Stage Malaria Vaccines (U01 Clinica...
Understanding Phage Biology to Support the Development of Bacteriophage Therapy (R21 Clini...
Strategies to Improve Health Outcomes and to Reduce Disparities in Rural Populations (R01 ...
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP) (R01 Clinical T...
Organotypic Culture Models developed from Experimental Animals for Chemical Toxicity Scree...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2019 FederalGrants.com